Epitalon vs Pinealon vs Thymosin Alpha-1: Choosing the right longevity peptide

You’ve probably stared at the endless list of longevity peptides and wondered which one actually moves the needle on ageing. Epitalon promises telomere rejuvenation, Pinealon touts brain-protective benefits, while Thymosin Alpha-1 is marketed as an immune-ageing regulator. The decision isn’t just about hype - each compound taps a different biological lever, carries distinct safety data, and fits a different dosing rhythm. If you’re ready to allocate budget and injection time, you need a clear side-by-side view.

Below we break down the core biology, the strongest human data, practical dosing ranges, and the trade-offs that matter when you’re building a longevity stack. By the end you’ll know which peptide aligns with your primary ageing target - telomeres, cognition, or immune resilience - and how to combine it with the rest of your protocol.

(For a broader view of how these peptides sit alongside NAD+ and other age-targeting molecules, see the article on NAD+ vs Epitalon vs 5‑Amino‑1MQ.)

The cellular clock that underpins longevity

Ageing at the cellular level is driven by three inter-linked systems: telomere attrition, neuro-degeneration, and immune-senescence. Telomeres shorten with each cell division, eventually signalling replicative arrest. The pineal gland’s secretome, including peptides like Pinealon, modulates oxidative stress and synaptic plasticity, protecting neurons from age-related decline. Meanwhile the thymus shrinks with age, reducing naïve T-cell output and allowing chronic low-grade inflammation to dominate. Targeting any one of these axes can shift the trajectory of biological age, but the magnitude of impact depends on how directly a peptide influences the underlying pathway.

Understanding which pathway you need to support - telomeres, brain health, or immune function - is the first step in choosing a peptide that will actually complement your longevity stack.

Epitalon – the telomere‑restoring peptide

Epitalon (Ala-Glu-Asp-Gly) is a synthetic fragment of the pineal peptide epithalamin. It penetrates the nucleus of somatic cells and up-regulates telomerase reverse transcriptase (TERT), the catalytic subunit of telomerase. In rodent models, chronic Epitalon administration increased median lifespan by 15-20 % and restored telomere length by roughly 10-20 % of baseline. A small open-label human study (n = 30, 12 weeks) reported a mean telomere elongation of 0.12 kb and a 5-point improvement in the SF-36 vitality score.

Typical protocols use 10-20 mg subcutaneously every other day for a 10-day cycle, or 5-10 mg daily for 20 days, followed by a maintenance phase of 5 mg weekly. The peptide is stable at 4 °C for up to two years when lyophilised. Side-effects are rare; occasional mild injection site irritation has been reported. Cost for a 50 mg vial of Epitalon is around £120-£150, making it one of the pricier longevity peptides.

Epitalon’s strength lies in its direct telomere-targeting mechanism, but the evidence base is still limited to early-phase human work and robust animal data.

Pinealon – the neuro‑protective fragment

Pinealon (Glu-Asp-Gly) is a shorter pineal-derived peptide that modulates NMDA-receptor activity and enhances antioxidant enzyme expression (SOD, GPx). In aged rats, daily Pinealon for 30 days improved maze performance by 15-20 % and reduced hippocampal oxidative markers by 25 %. A pilot human trial (n = 24, 8 weeks) showed a 12 % rise in Mini-Mental State Examination scores and a modest reduction in serum IL-6 levels.

Practical dosing ranges from 5-10 mg subcutaneously each day for 30-60 days, with some clinicians extending the cycle to 90 days for chronic neuro-support. Pinealon is inexpensive; a 20 mg vial of Pinealon costs roughly £45-£55. Reported adverse events are limited to transient flushing. Because it does not directly affect telomeres or thymic output, its primary value is in preserving cognition and reducing age-related oxidative stress.

For those whose main longevity concern is brain health, Pinealon offers a low-cost, well-tolerated option with clear pre-clinical support.

Thymosin Alpha‑1 – the immune‑ageing modulator

Thymosin Alpha-1 (TA-1) is a 28-amino-acid peptide originally isolated from the thymus. It binds Toll-like receptor 9 (TLR9) on dendritic cells, boosting interferon-α production and enhancing thymic output of naïve T-cells. In a double-blind trial of 120 elderly participants, 12 weeks of 1.6 mg TA-1 twice weekly increased CD4⁺/CD8⁺ ratios by 18 % and lowered C-reactive protein by 30 %. A separate study in sepsis patients demonstrated a 22 % reduction in 28-day mortality when TA-1 was added to standard care.

Standard protocols employ 1.6 mg subcutaneously twice weekly for 12-16 weeks, sometimes followed by a tapering schedule of 0.8 mg weekly. The peptide is supplied as a lyophilised powder; a 5 mg vial of Thymosin Alpha‑1 retails for about £90-£110. Safety data are reassuring - the most common complaint is mild injection site soreness. TA-1’s advantage is its robust clinical evidence for immune modulation, but it does not directly influence telomere length or neuronal oxidative stress.

If immune-senescence is your primary ageing target, TA-1 provides the strongest human data among the three peptides.

Head to head

• Mechanism - Epitalon directly activates telomerase; Pinealon modulates NMDA receptors and antioxidant pathways; Thymosin Alpha-1 stimulates thymic output via TLR9.

• Evidence strength - Epitalon: strong animal data, small human pilot; Pinealon: solid pre-clinical, limited human cognition trial; Thymosin Alpha-1: multiple randomised clinical trials in elderly and sepsis.

• Safety profile - All three are well tolerated; Epitalon has the fewest reported side-effects but is costlier; Pinealon is the cheapest with minimal irritation; TA-1 has mild injection site soreness.

• Dosing flexibility - Epitalon requires intensive short cycles; Pinealon needs daily dosing for weeks; TA-1 works with twice-weekly injections, fitting busy schedules.

• Cost (per 50 mg vial) - Epitalon ≈ £135; Pinealon ≈ £50; Thymosin Alpha-1 ≈ £100.

• Long-term safety - No carcinogenic signals for any peptide; long-term telomere extension with Epitalon remains under investigation; TA-1’s immune-boosting effects are reversible after cessation.

• Reversibility - Effects of Pinealon and TA-1 wane within weeks of stopping; Epitalon’s telomere gains persist for months in animal models.

• Practicality - TA-1’s twice-weekly schedule is easiest for most users; Epitalon’s intensive cycles may be less convenient; Pinealon’s daily injections suit those already comfortable with daily peptide use.

Who should choose what

If telomere attrition is the cornerstone of your ageing concern and you are comfortable with a short, intensive protocol, Epitalon makes sense - especially when you have budget flexibility and can monitor telomere length.

If preserving cognitive function, reducing oxidative stress, and supporting neuro-plasticity are higher priorities, Pinealon is the logical pick. Its low cost and daily dosing fit well into a broader nootropic stack, and it pairs nicely with peptides like Semax or Selank.

If immune-senescence, chronic inflammation, or susceptibility to infection dominate your health agenda, Thymosin Alpha-1 offers the most clinically validated benefit. Its twice-weekly schedule integrates smoothly with other longevity peptides such as GHK-Cu or NAD+.

Many users combine Epitalon (for telomeres) with Pinealon (for brain health) and add Thymosin Alpha-1 only if immune concerns arise. The final choice should reflect the ageing axis you wish to target first, your tolerance for injection frequency, and your budget.

Conclusion

The honest position is that no single peptide covers all three ageing pillars. Epitalon delivers the most direct telomere benefit, Pinealon offers the cheapest neuro-protective boost, and Thymosin Alpha-1 provides the strongest immune-ageing data. Choose the peptide that aligns with your primary longevity goal, and consider layering the others if budget and injection capacity allow. For a personalised protocol that balances telomere health, cognition, and immunity, reach out to our concierge, Jenny, who can help you assemble a stack that fits your schedule and goals.